UFP Technologies reported a decrease in sales and net income for Q4 2020 compared to Q4 2019. Sales declined by 10.1% to $45.2 million, and net income decreased by 27.6% to $4.2 million. The company highlighted its cost-cutting initiatives and efficiency improvements, which helped improve gross margins throughout the year. They also managed supply chain issues, kept staff safe, and improved cash balance.
Net income for Q4 2020 was $4.2 million, or $0.55 per diluted common share, compared to $5.8 million, or $0.77 per diluted common share, in Q4 2019.
Sales for Q4 2020 were $45.2 million, down from $50.3 million in Q4 2019.
Gross margins improved steadily throughout the year, reaching 25.2% in Q4.
The company's Product Development business grew by 63%.
UFP Technologies anticipates business improvements based on a rebound in elective surgeries and strong consumer and aerospace & defense markets. They have a strong balance sheet and will continue to evaluate acquisition opportunities.
Analyze how earnings announcements historically affect stock price performance